Tufts: Growing Volumes of Clinical Data are Slowing Drug Development

Drug Industry Daily
A A
Massive amounts of clinical trial data are lengthening drug development timelines as technical challenges create costly bottlenecks, according to a new industry survey from the Tufts Center for the Study of Drug Development.

To View This Article:

Login

Subscribe To Drug Industry Daily